Menu
GeneBe

TIMP2

TIMP metallopeptidase inhibitor 2, the group of Tissue inhibitor of metallopeptidases

Basic information

Region (hg38): 17:78852976-78925387

Links

ENSG00000035862NCBI:7077OMIM:188825HGNC:11821Uniprot:P16035AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TIMP2 gene.

  • Inborn genetic diseases (7 variants)
  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TIMP2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
7
clinvar
7
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
1
Total 0 0 7 1 0

Variants in TIMP2

This is a list of pathogenic ClinVar variants found in the TIMP2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-78855707-G-A not specified Uncertain significance (Oct 06, 2021)2218607
17-78855712-G-A TIMP2-related disorder Likely benign (May 09, 2022)3045371
17-78855756-C-T not specified Uncertain significance (Feb 27, 2024)3177577
17-78855812-A-G not specified Uncertain significance (Apr 08, 2022)2219702
17-78857541-T-A not specified Uncertain significance (May 24, 2023)2551285
17-78857596-C-T not specified Uncertain significance (Jan 31, 2023)2458879
17-78857625-T-C not specified Uncertain significance (Dec 20, 2023)3177575
17-78857629-C-T not specified Uncertain significance (Feb 06, 2023)2462734
17-78857638-C-T not specified Uncertain significance (Jun 03, 2022)2293892
17-78870935-C-T TIMP2-related disorder Benign (Jun 11, 2019)3059644
17-78873811-A-G TIMP2-related disorder Benign (Feb 18, 2019)3033608
17-78873857-G-C not specified Uncertain significance (Oct 13, 2023)3177574
17-78873903-C-T TIMP2-related disorder Likely benign (Sep 06, 2019)3040620
17-78892237-G-A Likely benign (Mar 01, 2023)2648382
17-78925022-G-A not specified Uncertain significance (Feb 01, 2023)2456633
17-78925053-G-A TIMP2-related disorder Benign (Oct 21, 2019)3038074

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TIMP2protein_codingprotein_codingENST00000262768 572411
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.7890.210125545021255470.00000797
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.61711210.5890.000007471444
Missense in Polyphen2051.630.38737594
Synonymous-0.03235453.71.010.00000436408
Loss of Function2.5619.500.1054.04e-7123

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.0001090.000109
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.0001090.000109
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Complexes with metalloproteinases (such as collagenases) and irreversibly inactivates them by binding to their catalytic zinc cofactor. Known to act on MMP-1, MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, MMP-10, MMP-13, MMP-14, MMP-15, MMP-16 and MMP-19. {ECO:0000269|PubMed:11710594, ECO:0000269|PubMed:2554304, ECO:0000269|PubMed:2793861}.;
Pathway
Matrix Metalloproteinases;Angiogenesis;Angiogenesis overview;IL1 and megakaryocytes in obesity;Vitamin D Receptor Pathway;Protein alkylation leading to liver fibrosis;Neutrophil degranulation;inhibition of matrix metalloproteinases;Extracellular matrix organization;Innate Immune System;Immune System;Activation of Matrix Metalloproteinases;Degradation of the extracellular matrix (Consensus)

Intolerance Scores

loftool
0.197
rvis_EVS
-0.32
rvis_percentile_EVS
31.46

Haploinsufficiency Scores

pHI
0.299
hipred
N
hipred_score
0.472
ghis
0.657

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.760

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Timp2
Phenotype
immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; normal phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype;

Zebrafish Information Network

Gene name
timp2a
Affected structure
whole organism
Phenotype tag
abnormal
Phenotype quality
decreased length

Gene ontology

Biological process
central nervous system development;aging;negative regulation of cell population proliferation;response to hormone;response to organic substance;negative regulation of endopeptidase activity;extracellular matrix disassembly;regulation of Rap protein signal transduction;response to cytokine;response to drug;neutrophil degranulation;positive regulation of MAPK cascade;positive regulation of neuron differentiation;positive regulation of adenylate cyclase activity;negative regulation of mitotic cell cycle;negative regulation of Ras protein signal transduction;negative regulation of membrane protein ectodomain proteolysis;negative regulation of metallopeptidase activity
Cellular component
extracellular region;extracellular space;cell surface;growth cone;extracellular matrix;specific granule lumen;neuronal cell body;collagen-containing extracellular matrix;tertiary granule lumen;ficolin-1-rich granule lumen
Molecular function
protease binding;integrin binding;protein binding;metalloendopeptidase inhibitor activity;zinc ion binding;peptidase inhibitor activity